One or more of the NCCCP’s four goals is shared by several NCI programs – including the NCI Cancer Centers Program, Community Clinical Oncology Program, Community Network Program, and others. The NCCCP will incorporate best practices from other NCI community cancer programs in delivering services to these communities.
Learn more about other NCI programs and initiatives by visiting the program Web sites below.
Cancer Centers Program-
The Cancer Centers Program supports 63 NCI-designated cancer centers nationwide that are actively engaged in transdisciplinary research to reduce cancer incidence, morbidity, and mortality.
The NCI-designated Cancer Centers are a major source of discovery of the nature of cancer and of the development of more effective approaches to cancer prevention, diagnosis, and therapy. They also deliver medical advances to patients and their families, educate health-care professionals and the public, and reach out to underserved populations. They are characterized by strong organizational capabilities, institutional commitment, and trans-disciplinary, cancer-focused science; experienced scientific and administrative leadership, and state-of-the-art cancer research and patient care facilities.
NCI-designated Cancer Centers are funded through the P30 Cancer Center Support Grant. These awards fund formal research programs that foster interactions between basic laboratory, clinical, and population scientists; access for investigators to shared services and technologies that are necessary to their research efforts; and other scientific infrastructure. Requests from eligible institutions are subjected to a competitive peer review process that evaluates and ranks applications according to their merit.
For more information visit: http://cancercenters.cancer.gov
- Community Clinical Oncology Program (CCOPs)
-
The Community Clinical Oncology Program (CCOP) is a network for conducting cancer prevention and treatment clinical trials by community medical practitioners. This network connects academic centers (Research Bases who design and conduct the trials) with community physicians who accrue patients to those trials.
Created in 1983 by NCI, the CCOP network allows patients and physicians to participate in state-of-the-art clinical trials for cancer prevention and treatment while in their local communities. There are 50 CCOPs and 13 MB-CCOPs (Minority-Based CCOP) currently funded in 35 states across the country, the District of Columbia, and Puerto Rico. MB-CCOPs are required to have 40% of their new cancer patients from minority populations.
For more information visit: http://www.cancer.gov/prevention/ccop
- Minority-Based Community Clinical Oncology Program (MB-CCOPs)
-
The Minority-Based Community Clinical Oncology Program (MB-CCOPs) was launched in 1990 as part of the efforts of the CCOPs to deliver the best cancer care to patients, wherever they live. At least 40 percent of the local populations served by MB-CCOPs are minorities and the programs have had a disproportionately positive effect: In 2003, for instance, the MB-CCOPs accounted for less than 20 percent of the CCOP network but enrolled half of the minority patients in the studies. (August 2 NCI Cancer Bulletin and August 2 Journal of Clinical Oncology.)
For more information visit: http://prevention.cancer.gov/programs-resources/programs/ccop
- Cancer Trials Support Unit (CTSU)
-
The Cancer Trials Support Unit (CTSU) is a pilot project sponsored by NCI for the support of a national network of physicians to participate in NCI-sponsored Phase III cancer treatment trials. The objectives of the program are to: increase physician and patient access to NCI-sponsored clinical trials, streamline and standardize trial data collection and reporting, and reduce regulatory/administrative burden on investigators participating in NCI-sponsored Cooperative Group clinical trials (phases 1-3)
For more information visit: http://www.ctsu.org/
- Community Network Program (CNP)
-
The Community Networks Program (CNP) aims to reduce cancer health disparities through community-based participatory education, training, and research among racial/ethnic minorities and underserved populations. The overall goal of the program is to significantly improve access to - and utilization of - beneficial cancer interventions and treatments in communities experiencing cancer health disparities in order to reduce these disparities.
For more information visit: http://crchd.cancer.gov/cnp/overview.html
- Cancer Disparities Research Partnership (CDRP)
-
The National Cancer Institute's Cooperative Planning Grant for Cancer Disparities Research Partnership (CDRP) Program issued by the Radiation Research Program is an effort to strengthen the national cancer program by developing models to reduce significant negative consequences of cancer disparities seen in certain U.S. populations. The Program supports the planning, development, and conduct of radiation oncology clinical trials in institutions that care for a disproportionate number of medically underserved, low-income, ethnic and minority populations but have not been traditionally involved in NCI-sponsored research. In addition, CDRP supports the planning, development, and implementation of nurturing partnerships between applicant institutions and committed and experienced institutions actively involved in NCI-sponsored cancer research.
For more information visit: http://www3.cancer.gov/rrp/CDRP/index.html
- Patient Navigation Research Program (PNRP)
-
The Patient Navigation Research Program (PNRP) aims to develop innovative patient navigation interventions to reduce or eliminate cancer health disparities and test their efficacy and cost-effectiveness. These interventions are designed to decrease the time between a cancer-related abnormal finding, definitive diagnosis, and delivery of quality standard cancer care services.
For more information visit: http://crchd.cancer.gov/pnp/pnrp-index.html
- Cancer Information Service (CIS)
-
The National Cancer Institute’s (NCI) Cancer Information Service (CIS) educates the public about cancer prevention, risk factors, symptoms, diagnosis, treatment, and research . CIS information specialists provide the latest, most accurate information about cancer by telephone, TTY, instant messaging, and e-mail and operates the NCI’s Smoking Quitline. Through its Partnership Program, the CIS works with established national, regional, and state organizations to reach those most in need of cancer information.
For more information visit: http://www.cancer.gov/cancertopics/factsheet/Information/CIS
- NCI Best Practices for Biospecimen Resources
-
The NCI Best Practices for Biospecimen Resources identifies best practices for biospecimen collection, processing, storage, retrieval, and dissemination and addresses concepts of good laboratory practice to ensure a level of consistency and standardization across NCI-supported biospecimen resources.
For more information visit: http://biospecimens.cancer.gov/NCI_Best_Practices_040507.pdf
- The Cancer Genome Atlas (TCGA)
-
The Cancer Genome Atlas (TCGA) is a large-scale collaborative effort by NCI and the National Human Genome Research Institute (NHGRI) to systematically characterize the genomic changes that occur in cancer through the application of genome analysis technologies, including large-scale genome sequencing.
For more information visit: http://tcga.cancer.gov
- Cancer Biomedical Informatics Grid (caBIGa™)
-
The cancer Biomedical Informatics Grid™, or caBIG™, is a voluntary network or grid connecting individuals and institutions to enable the sharing of data and tools, creating a World Wide Web of cancer research. The goal is to speed the delivery of innovative approaches for the prevention and treatment of cancer. The infrastructure and tools created by caBIG™ also have broad utility outside the cancer community. caBIG™ is being developed under the leadership of the National Cancer Institute's Center for Bioinformatics.
To learn more about caBIG™, visit : https://cabig.nci.nih.gov/
- Centers of Excellence in Cancer Communications Research (CECCR)
-
The Centers of Excellence in Cancer Communications Research initiative is the centerpiece of NCI’s Extraordinary Opportunity in Cancer Communications. The Request for Applications (RFA) used the P50 grant mechanism to invite applications for Centers that include three or more individual, hypothesis-driven research projects and a pilot or developmental research project process, cores, and plan for career development.
The novelty and scope of this initiative reflects the enormous potential of cancer communication to improve health, and NCI's recognition that effective communications can and should be used to narrow the gap between discovery and application and to reduce health disparities among our citizens. It is expected that the Centers' interdisciplinary efforts will result in new theories, methods, and interventions, including those for diverse populations. The Centers will provide essential infrastructure to facilitate rapid advances in knowledge about cancer communications, translate theory and programs into practice, and train health communication scientists. In essence, the Centers will catalyze major advances in cancer communication.
For more information visit: http://dccps.nci.nih.gov/hcirb/ceccr/
